Search

Chromatography Novasep Plans Large Chromatography Plant for the Pharmaceutical Industry

| Editor: Dominik Stephan

Novasep plans to build a new production facility for large volume commercial APIs (active pharmaceutical ingredient). The plant, build at Novasep's existing Mourenx site in France shall be operational by mid–2013, the company announced.

Related Companies

Novasep plans a new plant on its Mourenx, France site to produce a large volume commercial APIs
Novasep plans a new plant on its Mourenx, France site to produce a large volume commercial APIs
(Picture: PROCESS India)

Pompey/France – The new plant, designed by a Novasep in-house engineering team, will include the company's Varicol chromatography systems with 1,200 mm diameter columns operated at up to 70 bars, the largest ever built in the pharmaceutical industry. The plant will enable the production of a highly purified API from a complex mixture. The systems will also integrate sophisticated solvent recovery systems for the recycling of 99.9 per cent of solvents, resulting in both a very cost-effective and environmentally friendly process.

This € 30 million investment follows two other significant global investments in 2012. The first is the opening of a new 2,000 square meters facility in Shanghai, China and the second is a € three million investment to expand the Highly Potent API (HPAPI) manufacturing capabilities at the facility in Le Mans, France.

(ID:36057390)